Muzaffar, Jameel and Bari, Shahla and Kirtane, Kedar and Chung, Christine H. (2021) Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma. Cancers, 13 (2). p. 338. ISSN 2072-6694
![[thumbnail of cancers-13-00338-v2.pdf]](http://info.submit4journal.com/style/images/fileicons/text.png)
cancers-13-00338-v2.pdf - Published Version
Download (5MB)
Abstract
Head and neck squamous cell carcinoma (HNSCC) is the most common cancer arising in the head and neck region. The most common risk factors are smoking, excessive drinking, and human papillomavirus (HPV) infection. While the overall incidence of smoking is decreasing, the incidence of HPV-related HNSCC is increasing in the United States and Western Europe, which led to a shift in understanding of the pathophysiology, treatment, and prognosis of this disease. The outcomes for non-metastatic HNSCC remains very encouraging and continues to improve. Advances in radiation technology and techniques, better organ preserving surgical options, and multidisciplinary treatment modalities have improved cure rates for locally advanced HNSCC patients. The treatment of metastatic disease, however, remains an area of need. The advancement of immune checkpoint inhibitors has provided significantly better outcomes, but only a small proportion of patients obtain benefits. Most recurrent and/or metastatic HNSCC patients continue to have poor survival. This has led to the vigorous investigation of new biomarkers and biomarker-based therapies. Novel therapeutic options including adaptive cellular therapy and therapeutic vaccines are also on the horizon. In this review, we highlight the latest advances in the field of HNSCC and the future direction of research.
Item Type: | Article |
---|---|
Subjects: | Eurolib Press > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 11 Jan 2023 09:15 |
Last Modified: | 05 Jun 2024 09:32 |
URI: | http://info.submit4journal.com/id/eprint/519 |